SIBP-R002
Phase 1Small molecule
SIBP-R002 is one of 2 small molecule programs targeting Uncontrolled Gout. It is currently in Phase 1.
1
Indications
2
Total Trials
1
Active Trials
1
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
1 competitor in Uncontrolled Gout
#DrugCompanyPhaseTrials
1Trexall
Jazz PharmaceuticalsApproved
SIBP-R002
SShanghai Institute Of Biological Products
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for SIBP-R002. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details